From Wikipedia, the free encyclopedia
Capromab pendetide (tradename Prostascint) is a mouse monoclonal antibody used to image the extent prostate cancer.
|
Mouse monoclonal antibodies ("-o-") |
|
| "govo" (ovarian tumor) |
|
|
| "limo" (immune system) |
Afelimomab, Dorlimomab aritox, Elsilimomab, Faralimomab, Gavilimomab, Inolimomab, Maslimomab, Nerelimomab, Odulimomab, Telimomab aritox, Vepalimomab, Zolimomab aritox
|
|
| "tumo" (miscellaneous tumor) |
Altumomab, Anatumomab mafenatox, Arcitumomab, Bectumomab, Detumomab, Epitumomab, Epitumomab cituxetan, Ibritumomab tiuxetan, Minretumomab, Mitumomab, Naptumomab estafenatox, Nofetumomab merpentan, Pemtumomab, Pintumomab, Satumomab, Taplitumomab paptox, Tositumomab
|
|
| "leso" (infectious lesions) |
|
|
| "ciro" (cardiovascular) |
|
|
| "pro" (prostate tumor) |
|
|
| "baco" (bacterial) |
|
|
| "colo" (colonic tumor) |
|
|
